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Abstract 
 
In this work a high-power CO2 laser was used to irradiate powder blends of co-crystal 
formers, with the specific aim of trying to cause recrystallization to a co-crystal 
structure. By varying the power and raster speed of the laser, it was found that 
sufficient thermal energy could be imparted to the powder to cause molecular 
rearrangement. It was possible to form co-crystals of caffeine with oxalic acid and 
caffeine with malonic acid. Interestingly, it was found that to form co-crystals 
successfully, the co-formers needed to sublime to an appreciable extent, which 
indicates the mechanism of rearrangement involves interaction and nucleation in the 
vapour phase. Laser irradiation thus offers a new route to creation of pharmaceutical 
co-crystals and a potentially rapid screen for likely co-crystal formation between co-
forming pairs. 
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Introduction 
Many pharmaceutical products, especially those designed for oral delivery, contain 
an active drug in a crystalline state. In cases where the active drug exhibits 
polymorphism there is frequently a dichotomy between physicochemical properties 
(dissolution rate, solubility and bioavailability) and stability. Metastable forms usually 
have better physicochemical properties, but carry the risk of converting to a more 
stable form during storage. In cases where the bioavailability of a more stable form is 
unsatisfactory, demonstrating the stability of the metastable form is essential in 
getting regulatory permission for the product. For instance, the metastable form B of 
chloramphenicol palmitate has good oral bioavailability while the stable form A does 
not and as a consequence the limit of form A permissible in a product is strictly 
controlled1. 
 
Numerous crystal engineering approaches to produce metastable forms are used 
pharmaceutically, including formation of salts, hydrates and solvates. These forms 
are of importance, not just for their physicochemical properties but also because they 
may affect ease of manufacture, purification or patentability. In the past decade the 
concept of pharmaceutical co-crystals has been introduced, defined as solid forms 
with unit cells comprising at least two compounds both of which interact by hydrogen 
bonding and/or other non-covalent bonds both of which are ordinarily solids at room 
temperature and pressure2. Co-crystals open the intriguing formulation strategy of 
creating crystal forms with improved physicochemical properties and acceptable 
stability. The co-former may be a stabilising excipient or a second active drug. For 
example, co-crystals of indomethacin-saccharin3, norfloxacin-isonicotinamide4 or 
carbamazepine with various compounds5-8 show improved solubility while piracetam-
L-tartaric acid co-crystals show better hygroscopicity9.  
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Understanding whether a particular active drug can be formulated as a co-crystal is 
therefore commercially important. Screening for physical forms typically commences 
by growing crystals from solvents of different polarities, but this can be laborious and 
time consuming. For example, Seaton et al10 grew 2:1 co-crystals of benzoic acid 
(BA) and isonicotinamide (IsoNCT) from aqueous solution over 1 month. Such time 
scales are not particularly convenient for early development phase screening, when 
a rapid assessment of likely co-crystal formation is needed. Other methods, such as 
drop grinding11 or computational screening12, may be used but new methods for co-
crystal screening, especially if they are quick and utilise small amounts of material, 
will always be of value. 
 
In principle, any method that can break the crystal lattice bonds of the co-forming 
crystals and then allow mixing and reformation of bonds can be used to screen for 
co-crystals. We have shown previously how ink-jet printing small volumes of 
solutions can be used to prepare co-crystals, with the fast evaporation rates directing 
rapid crystallization often to metastable forms13. However, this approach requires the 
use of suitable solvents in which the co-formers have appreciable solubility and are 
suitable for printing. A solvent-free method would therefore be attractive.  
 
Since rapid heating above the melt followed by quench cooling should facilitate 
molecular rearrangement, we wondered whether irradiating a dry powder blend of 
co-crystal formers with a high-power source, in this case a carbon dioxide (CO2) 
laser, might be an effective approach. CO2 lasers have many applications in the 
medical (tissue ablation)14 and chemical (fabrication of microfluidic arrays)15 but we 
are not aware of any studies reporting their use for changing the crystalline form of a 
solid sample. Hence, the specific aim of this work was to determine whether CO2 
laser irradiation of a powder blend facilitated co-crystal formation. We tested the 
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hypothesis with a training set of known co-crystal formers and report the effect of 
irradiation parameters on the success and/or extent of conversion. 
 
Materials and methods  
 
Caffeine (CAF), oxalic acid (OXA), malonic acid (MALO), water (HPLC grade), 
methanol, ethanol and chloroform were purchased from Sigma-Aldrich (UK) and 
used as received. 
 
Preparation of co-crystals by CO2 laser irradiation 
 
A 40W CO2 laser (Full Spectrum Laser LLC, Las Vegas, US) was used for this study. 
An image of a square (3cm x 3cm, 300 dpi) was used as a template for irradiation 
experiments. Binary dry powder blends of co-formers (respective masses CAF, 19.41 
mg, OXA, 9.0 mg, MALO, 10.41 mg), prepared by physically shaking and tumbling 
the powders in a sample vial for 5 min, were spread as a thin layer over aluminium 
foil (covering an area of the 3cm x 3cm). The focal length of the laser was 6.8 cm. 
The laser allows user variation of power (P) and raster speed (S); various 
combinations were used (S60 and S50; P50 and P60; the number reflects the 
percentage of the maximum speed or power that the laser could achieve). Irradiated 
samples were removed from the foil to a small vial and stored in a desiccator over 
phosphorous pentoxide at ambient temperature until further analysis. 
 
Preparation of reference co-crystals 
 
All reference co-crystals were prepared by slow evaporation according to literature 
methods. CAF:OXA was prepared by dissolving CAF (4.85 g) and OXA (1.12 g) in 
7:2 MeOH:CHCl3 (90 mL). CAF:MALO was prepared by dissolving CAF (1.43 g) and 
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MALO (0.38 g) in 30:1 MeOH:CHCl3 (30 mL). Solutions were kept at room 
temperature to allow the slow evaporation and precipitation. When the crystals had 
formed, they were isolated by filtration and stored in a desiccator over phosphorous 
pentoxide at ambient temperature until further analysis. 
 
X-Ray Powder Diffraction (XRPD) 
 
Data were collected on a Miniflex 600 diffractometer (Rigaku, Tokyo, Japan) with Cu 
Kα radiation at 40 kV and 15 mA using a zero background holder. Scanning was 
performed from 5°-35° 2θ at 0.01° 2θ step size and speed 5° 2θ/min.  
 
Differential Scanning Calorimetry (DSC) 
 
DSC measurements were made with a Q2000 (TA Instruments, LLC, USA). Samples 
(3-5 mg) were encapsulated in Tzero aluminium pans and lids. The heating rate was 
100 °C/min and a nitrogen purge (50 mL/min) was used. The instrument was 
calibrated using a standard reference material (indium, Tm = 156.6, ΔH = 28.71 J/g) 
in accordance with the manufacturer’s instructions. Data were analysed with 
Universal Analysis 2000 (TA Instruments, LLC, USA). Experiments were performed 
in triplicate, and the crystallization and melting values were reported as extrapolated 
onset (Tonset).  
 
Fourier-Transform Infrared (FT-IR) 
 
Data were obtained with a 100 FT-IR spectrophotometer (Perkin Elmer). The 
spectrum of an empty cell was used as the background. The scan was performed in 
the range of 4000 to 650 cm-1 for each sample at ambient conditions. Spectrum 
Express software (version 2008) was used to process the data. 
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Scanning Electron Microscopy (SEM) 
 
Samples were mounted on an aluminium stage using adhesive tape and sputter-
coated with gold (Quorum model Q150, Quorum Technology, UK) at 40 mA. Images 
were collected using an SEM (SEM, Quanta 200 FEG, FEI, Netherlands).   
 
Results and discussion  
 
The general principle by which laser irradiation might be expected to change physical 
form is that during irradiation a lot of energy is imparted to the sample, causing a 
rapid, but localised, rise in temperature. Because the laser is moved in a raster 
pattern across the sample, energy is imparted for only a short (<1 s) period of time, 
so there should be a relatively rapid fall in temperature back to that of the stage. 
Thus, crystalline particles melt, mix and are then forced to crystallise rapidly upon 
cooling. If a co-crystal solid form thermodynamically easier to form (i.e. if it is 
metastable with respect to either of the starting crystalline forms of the individual 
components) then co-crystals should result after irradiation. The balance of power 
(P) and raster speed (S) is important because it is necessary to impart to the sample 
enough energy for it to rise sufficiently in temperature to melt, but not so much that it 
degrades. It is also necessary to ensure the powder blends are thoroughly dry-mixed 
prior to irradiation and that they are spread thinly, so that all the material is heated 
sufficiently to melt. 
 
The CAF:OXA system represents a non-congruently soluble co-crystal pair that can 
be quite challenging to co-crystallise. Trask et al16, successfully prepared 2:1 
CAF:OXA by co-grinding and slow solvent evaporation while Daurio et al17 used hot-
melt extrusion. XRPD patterns for the 2:1 CAF:OXA system are shown in Figure 1. It 
is apparent that the patterns for the irradiated samples are different from those of the 
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starting materials or the physical blend, and match the pattern of the reference co-
crystal. In particular, the characteristic intensity maxima at 11.2° and 22.3° seen for 
CAF and OXA starting materials respectively are absent from the co-crystal and 
irradiated patterns, while intensity maxima at 11.3, 12.0, 15.7, 17.1, 18.1, 21.8, 24.2, 
26.6, 27.7, 28.2, 29.9, 30.8 and 32.0°), characteristic of the co-crystal and in good 
agreement with the literature17-21, are seen in both irradiated samples. In all cases, 
irradiation with settings of P50:S50 produced slightly better co-crystals than 
irradiation at P60:S60. Irradiating at higher powers tended to degrade samples and 
irradiating at lower powers did not result in clear formation of co-crystals (data not 
shown). 
 
Further characterisation of the physical form of the irradiated samples was performed 
with DSC and FTIR. Note here that we opted to use fast heating rates in the DSC 
because these increase the signal-to-noise ratio of the data while also minimising the 
time the sample is exposed to high temperatures (which is particularly important 
when studying metastable physical forms22). The DSC data, Figure 2, clearly show 
that the melting point of the reference co-crystal and irradiated samples, 210 oC, was 
different from that of the pure compounds and physical mixture. Melting of the co-
crystal at 210 oC is in good agreement with literature17, 20. Pure CAF sublimes at 178 
oC and melts at 236 °C (in an open pan, melting would not be observed) while pure 
OXA shows numerous endothermic transitions, again ascribed to 
sublimation/melting. The absence of any sublimation peaks from the irradiated 
samples is good evidence that the co-crystal has formed. The physical mixture also 
shows evidence of the co-crystal melt, presumably because the co-crystal itself has 
formed during heating in the DSC. This observation substantiates the idea that 
physical form change during irradiation with the laser occurs because of a rapid rise 
in temperature. The sample irradiated at settings of P60:S60 showed characteristics 
of the powder blend, in that the melting endotherm at ca. 210 oC was a doublet and 
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an additional endotherm was seen at ca. 160 oC. In agreement with the XRPD data 
discussed above, this indicates that irradiating the sample at the higher power 
probably caused some degradation of the co-formers. 
 
FT-IR spectra, Figure 3, confirm the irradiated samples have the same absorbance 
bands as the reference co-crystal. The C=O bending and stretching bands shifted 
from 700, 743, 1646 and 1695 cm-1 for CAF to 706, 748, 1659 and 1700 cm-1 for the 
co-crystal and irradiated samples, while C-H bending bands shifted from 862 and 
1239 cm-1 to 899 and 1228 cm-1. In addition, a change in hydrogen bonding was 
observed in the C-H stretching band, which shifted from 3112 cm-1 in the pure 
material to 3121 cm-1 in the co-crystal and irradiated samples19, 21, 23-24. On the other 
hand, the IR spectrum of the physical mixture matched those of CAF and OXA when 
superimposed, indicating there was no interaction between CAF and OXA after 
mixing. 
 
SEM images (Figure 4) reveal differences in morphology and size between the 
starting materials, reference co-crystals and irradiated samples. Pure CAF was 
clumped with needle-shaped crystals, while OXA was seen as large plates. All the 
irradiated samples showed clusters of needle-like crystals, similar to the reference 
co-crystals. One difference between the irradiated samples and the reference co-
crystal was the particle size, the irradiated samples containing smaller crystals. The 
reference prepared from solvent crystallization was found to be large and plate-like 
(ca. 50 µm), which is in good agreement with previous studies18-19. Chung and Kim19 
noted nano co-crystals could be obtained by adding polymers, while laser irradiation 
produced crystals of ca. 5 µm. The small size is probably because molecular 
rearrangement and crystal growth can only occur while the material has sufficient 
energy following irradiation, and this is likely to be for a short time. One potential 
application of this approach, therefore, is preparation of particles for pulmonary 
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delivery, where an average particle size below 5 m is required for successful 
delivery to the lung. 
 
Formation of the 2:1 CAF:MALO co-crystal has been reported by solvent evaporation 
and solid-state grinding16, 21. The XRPD patterns recorded here, Figure 5, show that 
the irradiated samples had the same characteristic set of intensity maxima (7.6, 11.0, 
12.2, 15.6, 17.3, 17.7, 18.7, 20.3, 21.9, 22.8, 23.2, 24.6, 27.2, 28.4, 30.6 and 31.4°) 
as the reference co-crystal, while the characteristic maxima for CAF and MALO 
(11.2° and 23.2°, respectively) were absent. The patterns are consistent with those 
reported by Nishijo et al21. 
 
The DSC data, Figure 6, show melting of the co-crystal at ca. 132 oC, with a higher 
temperature endotherm at ca. 231 °C, most likely associated with possible 
recrystallisation and sublimation of CAF. The thermal behaviour of the irradiated 
samples matches that of the co-crystal. The thermal trace of the physical mixture is 
complex, showing a broad endotherm commencing at ca. 100 oC. Since this 
corresponds to the melting point of MALO, it may be the case that the data reflect 
melting of MALO, possible dissolution and/or recrystallization with CAF and then 
sublimation of CAF at higher temperatues. It is clear, however, that the co-crystal 
was not present initially in powder blend.  
 
The FTIR spectra, Figure 7, confirm the irradiated samples have similar bonding to 
the reference co-crystal. The bands associated with C=O bending and stretching shift 
from 700, 743, 744, 1646, 1645 and 1695 cm-1 for CAF to 706, 748, 1659, 1657 and 
1700 cm-1 for the 2:1 CAF:MALO co-crystal and irradiated samples, while the 
absorption bands of the C-H bending shift from 862 and 1239 cm-1 to 902 and 1228 
cm-1. Changes in hydrogen bonding are seen in the C-H stretching vibration, which 
shifts from 3112 and 3109 cm-1 to 3121 and 3122 cm-1 while new interactions in the 
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co-crystal are indicated by N-H stretching, C=O and C-H vibrations at 3122, 1698, 
1658 and 1611 cm-1. The spectrum of the physical mixture matched those of CAF 
and MALO when superimposed, which indicated that there was no interaction 
between CAF and MALO after mixing.  
 
Finally, visual confirmation that a change in morphology occurs upon irradiation is 
provided by SEM images, Figure 8. While the larger crystals of MALO are not seen in 
the irradiated samples, needle-like crystals are seen emerging from a homogeneous 
core. 
 
Interestingly, although the results are not shown here, we were only able to make co-
crystals with powder mixtures where at least one co-former showed significant 
sublimation (both caffeine and malonic acid sublime to an appreciable extent, while 
oxalic acid shows a small extent of sublimation). This suggests that the mechanism 
is more complex than just a simple rise in temperature melting the material as the 
laser moves across the powder bed. Dhumal et al25 suggested a mechanism to 
explain co-crystallization by solid-state grinding involving mass transfer via vapour 
diffusion. In this model, nuclei form in the highly saturated and stoichiometric vapour 
above the molten sample. Vapourised material then re-condenses to form crystals on 
a substrate where co-crystal growth occurs. It seems likely that a mechanism of this 
sort, involving interaction of compounds in the gaseous state, is involved with laser 
irradiation and this explains when the whole sample can convert to a new crystal 
form, even though it is the surface of the powder that is exposed to irradiation 
energy. 
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Conclusion 
 
CO2 laser irradiation has been demonstrated as a novel, rapid and solvent-free 
method for the preparation of pharmaceutical co-crystals. Co-crystals of 2:1 
CAF:OXA and 2:1 CAF:MALO were successfully produced. Various parameters, 
such as laser speed and laser power, were found to be key factors in producing high 
quality co-crystals. Co-crystals were only successfully produced from co-formers that 
were sublimable, indicating that nucleation in the vapour phase was the probably 
mechanism of formation.  
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Figure 1: X-ray powder diffraction patterns for caffeine and oxalic acid, 
showing reference patterns for the crystalline starting materials, a physical 
mixture (PHY), a reference co-crystal prepared from solution (sol) and samples 
irradiated at various P and S settings. 
 
  
 16 
0 100 200
2:1 CAF:OXA S50P50
2:1 CAF:OXA S60P60
Temperature (C)
CAF
2:1 CAF:OXA PHY
OXA
Exo up
COCRYS solH
ea
t 
F
lo
w
 (
m
W
/g
)
 
Figure 2. DSC thermal traces for CAF and OXA, a physical mixture (PHY), a 
reference co-crystal prepared from solution (sol) and samples irradiated at 
various P and S settings. 
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Figure 3. FTIR spectra for CAF and OXA, a physical mixture (PHY), a reference 
co-crystal prepared from solution (sol) and samples irradiated at various P and 
S settings. 
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Figure 4. SEM images of (from top to bottom) CAF, OXA, the reference co-
crystal, S50:P50 and S60:P60. 
 19 
 
 
 
 
5 10 15 20 25 30 35
In
te
n
si
ty
2 (degrees)
CAF
COCRYS sol
MALO
2:1 CAF:MALO S60P60
2:1 CAF:MALO S50P50
2:1 CAF:MALO PHY
 
 
Figure 5: X-ray powder diffraction patterns for caffeine and malonic acid, 
showing reference patterns for the crystalline starting materials, a physical 
mixture (PHY), a reference co-crystal prepared from solution (sol) and samples 
irradiated at various P and S settings. 
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Figure 6. DSC thermal traces for CAF and MALO, a physical mixture (PHY), a 
reference co-crystal prepared from solution (sol) and samples irradiated at 
various P and S settings 
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Figure 7. FTIR spectra for CAF and MALO, a physical mixture (PHY), a 
reference co-crystal prepared from solution (sol) and samples irradiated at 
various P and S settings 
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Figure 8. SEM images of (from top to bottom) CAF, MAL, the reference co-
crystal, S50:P50 and S60:P60. 
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